THE IMPORTANCE OF REHABILITATION AND CARE FOR PATIENTS WHO HAVE SUFFERED A MYOCARDIAL INFARCTION
Keywords:
Myocardial Infarction, Cardiac Rehabilitation, Physical Therapy, Lifestyle Modifications, Psychological SupportAbstract
Myocardial infarction (MI) is a major cause of death and disability globally, necessitating immediate medical intervention and effective post-acute care. Rehabilitation and continuous care are crucial for long-term recovery and reducing future cardiovascular events. This article examines the role of comprehensive rehabilitation in MI recovery.Despite evidence supporting rehabilitation, gaps exist in understanding the long-term benefits of rehabilitation components, patient adherence, and access disparities.A systematic review of recent literature was conducted using PubMed, Scopus, and Google Scholar, focusing on studies related to MI rehabilitation, including physical therapy, lifestyle modifications, and psychological support. Data were analyzed for effectiveness and challenges, with quality assessed using standard tools.Structured exercise programs, lifestyle changes, and psychological support significantly improve recovery outcomes. Exercise therapy showed a 25% reduction in mortality; lifestyle modifications reduced cardiovascular risk factors and improved lipid profiles; psychological support enhanced adherence and reduced anxiety and depression.Combining physical exercise, lifestyle adjustments, and psychological support in MI rehabilitation leads to improved cardiovascular health, reduced mortality, and lower recurrence rates. These components collectively enhance patient recovery and reduce the risk of future myocardial infarction.Integrating a multidimensional rehabilitation approach into standard practices is essential for optimizing patient care. Future research should explore long-term effects of rehabilitation, personalized plans, and strategies to improve access to care, especially for underserved populations.
References
1. Alisherovna K. M. et al. QUALITY OF LIFE IN THE PATHOLOGY OF THE CARDIOVASCULAR SYSTEM //World Bulletin of Public Health. – 2023. – Т. 25. – С. 35-40.
2. Bekmuradova M. S., Gafforov K. K., Yarmatov S. T. The value of brain natriuretic peptide determination in the diagnosis of chronic heart failure //Achievements in science and education. – 2020. – Т. 4. – С. 58.
3. Briffa TG, et al. Population trends of recurrent coronary heart disease event rates remain high. Circ Cardiovasc Qual Outcomes. 2011;4(1):107–13.
4. Guerra E, et al. Microvascular obstruction in patients with non-ST-elevation myocardial infarction: a contrast-enhanced cardiac magnetic resonance study. Int J Cardiovasc Imaging. 2014;30(6):1087–95.
5. Khan MA, Hashim MJ, Mustafa H, Baniyas MY, Buti Mohamad Al Suwaidi SK, AlKatheeri R. Global epidemiology of ischemic heart disease: results from the global burden of disease study. Cureus. 2020;12(7):e9349.
6. Kolo PM, et al. Changing trend in the incidence of myocardial infarction among medical admissions in Ilorin, north-central Nigeria. Niger Postgrad Med J. 2013;20(1):5.
7. Misumida N, et al. Association between preinfarction angina and angiographic findings in non–ST-segment elevation myocardial infarction. Clin Cardiol. 2015;38(9):535–41.
8. Nazarov F. Y., Bekmuradova M. S. RESEARCH OF LOCAL CONTRACTABILITY OF THE MYOCARDIAL WITH THE HELP OF TISSUE DOPPLERA STREETS SUFFERING WITH DILATED CARDIOMYOPATHY //Galaxy International Interdisciplinary Research Journal. – 2022. – Т. 10. – №. 1. – С. 317-319.
9. Salkhidinovna B. M., Abrorovna V. N. The Relationship Between Elevated Pulse Pressure and Natriuretic Peptide //Miasto Przyszłości. – 2022. – Т. 25. – С. 119-121.
10. Schmidt M, et al. 25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study. BMJ. 2012;344:e356.
11. Sulo G, et al. Favourable trends in incidence of AMI in Norway during 2001–2009 do not include younger adults: a CVDNOR project. Eur J Prev Cardiol. 2014;21(11):1358–64.
12. Vafoeva N. A., Bekmuradova M. S. Important Aspects of the Treatment of Chronic Heart Failure. – 2022.
13. Yarmukhamedova S. et al. Study of indicators of intracardial hemodynamics and structural state of the myocardium in monotherapy of patients with arterial hypertension with moxonidin //Journal of Advanced Medical and Dental Sciences Research. – 2020. – Т. 8. – №. 9. – С. 78-81.
14. Yarmukhamedova S. K., Bekmuradova M. S. The development of heart failure in patients with essential hypertension in terms of natriuretic peptide //Eurasian Journal of Cardiology S. – 2019. – Т. 1. – С. 283-284.
15. Yarmukhamedova S. K., Bekmuradova M. S., Nazarov F. Y. Diagnostic value of natriuretic peptide in identifying patients with asymptomatic systolic or diastolic dysfunction //Achievements of science and education. – 2020. – Т. 8. – №. 62. – С. 84-88.
16. Zhang D, et al. The effects of tirofiban on acute non-ST segment elevation myocardial infarction patients not receiving early reperfusion intervention. Zhonghua Nei Ke Za Zhi. 2014;53(3):193–7.
17. Бекмурадова М. С., Гаффоров Х. Х., Ярматов С. Т. Значение определения мозгового натрийуретического пептида в процессе диагностики хронической сердечной недостаточности //Достижения науки и образования. – 2020. – №. 4 (58). – С. 75-78.
18. Бекмурадова М. С., Махмудова Х. Д., Назаров Ф. Ю. ДИАГНОСТИЧЕСКАЯ ЗНАЧИМОСТЬ МОЗГОВОГО НАТРИЙУРЕТИЧЕСКОГО ПЕПТИДА ПРИ ВЫЯВЛЕНИИ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ //Scientific progress. – 2021. – Т. 2. – №. 1. – С. 810-814.
19. Бекмурадова М. С., Хайдаров С. Н. Связь между повышенным пульсовым давлением и натрийуретическим пептидом //Journal of cardiorespiratory research. – 2022. – Т. 3. – №. 1. – С. 26-29.
20. Ярмухамедова С. Х., Бекмурадова М. С., Назаров Ф. Ю. Диагностическая ценность натрийуретического пептида при выявлении пациентов с бессимптомной систолической или диастолической дисфункцией //Достижения науки и образования. – 2020. – №. 8 (62). – С. 84-88.
21. Ярмухамедова С. Х., Бекмурадова М. С., Назаров Ф. Ю. Значение уровня мозгового натрийуретического пептида в ранней диагностике хронической сердечной недостаточности у больных с артериальной гипертонией //Достижения науки и образования. – 2020. – №. 4 (58). – С. 61-63.
